Protein Sumoylation in OOCYTE Development
Protein Sumoylation in OOCYTE Development
批准号:
9888385
负责人:
STEPHANIE A. PANGAS
金额:
$32.89万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-02-01 至 2022-01-31
关键词:
AffectAgeAge-MonthsAneuploidyBirthCRISPR/Cas technologyCandidate Disease GeneCell physiologyCessation of lifeChromosome abnormalityChromosomesCongenital AbnormalityDNA BindingDataDefectDevelopmentDiagnosticDiseaseEmbryoEmbryonic DevelopmentEnterobacteria phage P1 Cre recombinaseEnzymesFeedbackFemaleFemale sterilityFertilityGene DeletionGene ExpressionGeneral PopulationGenerationsGenesGenetic TranscriptionGenotypeGerm CellsGoalsGrowing FollicleGrowth Differentiation Factor 9HealthHeart DiseasesHomeobox GenesHot flushesHumanIn VitroInfertilityKnock-outLeadLongevityMediatingMeiosisMenopauseMusMutateMutationNewborn InfantOocytesOvarian FollicleOvaryPathway interactionsPhenotypePost-Translational Protein ProcessingPregnancy lossPremature MenopausePremature Ovarian FailurePrimordial FollicleProcessProteinsProteomeProteomicsPubertyRegulationReproductive TechnologyResourcesRoleSecondary toSiteSterilityTestingVisionWomanWomen&aposs Healthbone lossdesignearly experienceeggfemale fertilityfolliculogenesisgenome editingimplantationin silicoin vivo evaluationinsightintraovarianmalemouse modelnegative affectnoveloocyte maturationovarian reservepostnatalprematureprimary ovarian insufficiencyprotein functionreproductivesegregationtooltranscription factortranscriptome sequencingtranscriptomicsyoung adult
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
Reproductive lifespan in women spans puberty to the menopause. However, in about 1-2% of women, early
menopause occurs, and this has negative health consequences, including increases in heart disease, bone
loss, hot flashes, or even early death. The number of oocytes found in the non-growing pool of ovarian follicles
(the "ovarian reserve"), is currently thought to largely determine the age at the menopause. Thus, premature
menopause arises if oocytes are dysfunctional or damaged. Mouse models demonstrate that oocyte-specific
transcription factors are required for the development of oocytes within the ovarian reserve. Deletion of these
genes, which includes newborn ovary homeobox gene (Nobox), causes female sterility and premature loss of
oocytes in mice. Furthermore, women with premature ovarian failure frequently have mutations in NOBOX.
Even though NOBOX is required for oocyte development, there is little to no information on how NOBOX
function is regulated. In silico analysis of NOBOX identified SUMOylation as a potential regulatory mechanism.
SUMOylation is a posttranslational modification that controls protein stability, localization, and activity,
particularly for transcription factors. However, the function of SUMOylation during intraovarian oocyte
development is not known. Therefore, we generated a novel oocyte-specific knockout of Ubc9, which is a
central component of the SUMOylation cascade. Loss of Ubc9 in oocytes beginning at the primordial follicle
stage caused female sterility and a full depletion of the oocyte reserve in young adult mice. Preliminary data
indicate that loss of SUMOylation affects NOBOX function and the phenotype manifests at the primary to
secondary follicle stage. The Aims of this project designed to (1) determine why there are defects in oocyte
development at the primary to secondary follicle stage and (2) elucidate how SUMOylation alters oocyte-
specific transcription factor function, resulting in altered gene expression and oocyte death/survival. The results
from these Aims will provide insight into the regulation of key oocyte-specific transcription factors and the
genesis of premature ovarian failure. Importantly, these studies will establish SUMOylation as an essential
process in intraovarian oocyte development.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Grem1 and Grem2 in embryonic ovary development
-
批准号:10584129
-
项目类别:
-
资助金额:$32.0万
-
财政年份:2023
-
负责人:STEPHANIE A. PANGAS
-
依托单位:
A functional neddylation pathway underlies oocyte quality and aging
-
批准号:10509284
-
项目类别:
-
资助金额:$24.0万
-
财政年份:2022
-
负责人:STEPHANIE A. PANGAS
-
依托单位:
A functional neddylation pathway underlies oocyte quality and aging
-
批准号:10672284
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2022
-
负责人:STEPHANIE A. PANGAS
-
依托单位:
Comprehensive Mechanisms in Reproductive Sciences
-
批准号:10403524
-
项目类别:
-
资助金额:$40.69万
-
财政年份:2020
-
负责人:STEPHANIE A. PANGAS
-
依托单位:
Comprehensive Mechanisms in Reproductive Sciences
-
批准号:10615873
-
项目类别:
-
资助金额:$41.72万
-
财政年份:2020
-
负责人:STEPHANIE A. PANGAS
-
依托单位:
Protein Sumoylation in OOCYTE Development
-
批准号:9247323
-
项目类别:
-
资助金额:$32.89万
-
财政年份:2017
-
负责人:STEPHANIE A. PANGAS
-
依托单位:
Role of the BMP SMADs in Oncogenesis
-
批准号:8205009
-
项目类别:
-
资助金额:$35.44万
-
财政年份:2010
-
负责人:STEPHANIE A. PANGAS
-
依托单位:
Role of the BMP SMADs in Oncogenesis
-
批准号:7984699
-
项目类别:
-
资助金额:$16.24万
-
财政年份:2010
-
负责人:STEPHANIE A. PANGAS
-
依托单位:
Role of the BMP SMADs in Oncogenesis
-
批准号:8091353
-
项目类别:
-
资助金额:$35.44万
-
财政年份:2010
-
负责人:STEPHANIE A. PANGAS
-
依托单位:
Role of the BMP SMADs in Oncogenesis
-
批准号:8403720
-
项目类别:
-
资助金额:$33.31万
-
财政年份:2010
-
负责人:STEPHANIE A. PANGAS
-
依托单位:
Role of Tudor Domain Protein 1 in Mouse Germ Cells
-
批准号:6954189
-
项目类别:
-
资助金额:$4.89万
-
财政年份:2004
-
负责人:STEPHANIE A. PANGAS
-
依托单位:
Role of Tudor Domain Protein 1 in Mouse Germ Cells
-
批准号:7108661
-
项目类别:
-
资助金额:$5.2万
-
财政年份:2004
-
负责人:STEPHANIE A. PANGAS
-
依托单位:
Role of Tudor Domain Protein 1 in Mouse Germ Cells
-
批准号:6835584
-
项目类别:
-
资助金额:$4.11万
-
财政年份:2004
-
负责人:STEPHANIE A. PANGAS
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: